BioSpace News Archive

Business

Can-Fite Signs Multi-Million Dollar Development and Distribution Agreement for Piclidenoson and Namodenoson in China with CMS Medical

Upfront and milestone payments total up to $74.5M plus double-digit royalties

August 6, 2018
·
6 min read
Policy

China National Drug Administration Approves Gilead’s Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide), a Single Tablet Regimen for the Treatment of HIV-1 Infection

Genvoya is the First TAF-Based Regimen Approved in China for Adults and Adolescents with HIV

August 6, 2018
·
9 min read
Business

bluebird bio and Regeneron Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer

The collaborators will specifically leverage Regeneron’s VelociSuite® platform technologies for the discovery and characterization of fully human antibodies

August 6, 2018
·
11 min read
FDA

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets

Methadone is indicated for the management of pain severe enough to require daily, around-the-clock long-term opioid treatment and for which alternative treatment options are inadequate.

August 6, 2018
·
3 min read
Genetown

Bruker Announces Ultra-High Field NMR Orders from Major NMR Infrastructure Investment in the UK

Investment of £20 Million for Eight UK Universities Includes Two 1 GHz Systems

August 6, 2018
·
4 min read
Business

Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers

Exclusive license agreement potentially worth more than $120 million in addition to royalties

August 6, 2018
·
4 min read
Biotech Bay

Protagonist Therapeutics Secures $22 Million Equity Financing

The transaction is expected to close on Aug. 8, 2018.

August 6, 2018
·
3 min read
Business

Henry Schein Reports Record Second Quarter 2018 Financial Results

GAAP diluted EPS of $0.92 increased by 7.0% over prior-year GAAP diluted EPS

August 6, 2018
·
60 min read
Business

Gamida Cell Expands its Leadership Team with the Appointment of Jaren Madden as Vice President, Investor Relations and Corporate Communications

Ms. Madden brings nearly 20 years of strategic communications experience to this new role at Gamida Cell, and will be responsible for the company’s engagement with the investment community as well as leading Gamida Cell’s media relations activities.

August 6, 2018
·
2 min read
Drug Development

Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA

Menarini Ricerche announced that the sponsorship of the ongoing Phase I/II study that is investigating MEN1703/SEL24 for the treatment of patients with relapsed/refractory (R/R) AML in the USA has been transferred from Selvita to Menarini Ricerche on June 30th 2018.

August 6, 2018
·
2 min read